Retatrutide is a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, https://tessjqzc271892.ampblogs.com/tirzepatide-a-promising-new-treatment-for-obesity-72949568